Ethoheptazine
Star0
Identification
- Generic Name
- Ethoheptazine
- DrugBank Accession Number
- DB08988
- Background
Ethoheptazine is marketed under the name Zactane. It is a phenazepine based opioid analgesic. It was invented in the 1950s and is related to other drugs such as proheptazine. Ethoheptazine is no longer marketed in the United States.
- Type
- Small Molecule
- Groups
- Approved, Withdrawn
- Structure
- Weight
- Average: 261.3593
Monoisotopic: 261.172878985 - Chemical Formula
- C16H23NO2
- Synonyms
- Ethoheptazin
- Ethoheptazine
- Ethoheptazinum
- Etoheptazina
- External IDs
- Wy 401
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Product Ingredients
Ingredient UNII CAS InChI Key Ethoheptazine citrate LXK8EE245D 6700-56-7 KCVHFFSPDODYOG-UHFFFAOYSA-N Ethoheptazine hydrochloride 8KYO8O8JNO 5982-61-6 XHRYXPJUXHWWJD-UHFFFAOYSA-N - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Equagesic Tablets Ethoheptazine citrate (75 mg / tab) + Acetylsalicylic acid (250 mg / tab) + Meprobamate (200 mg / tab) Tablet Oral Wyeth Ayerst Canada Inc. 1995-12-31 1997-01-14 Canada
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as azepanes. These are organic compounds containing a saturated seven member heterocycle, with one nitrogen atom.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Azepanes
- Sub Class
- Not Available
- Direct Parent
- Azepanes
- Alternative Parents
- Aralkylamines / Benzene and substituted derivatives / Trialkylamines / Carboxylic acid esters / Amino acids and derivatives / Monocarboxylic acids and derivatives / Azacyclic compounds / Organopnictogen compounds / Organic oxides / Hydrocarbon derivatives show 1 more
- Substituents
- Amine / Amino acid or derivatives / Aralkylamine / Aromatic heteromonocyclic compound / Azacycle / Azepane / Benzenoid / Carbonyl group / Carboxylic acid derivative / Carboxylic acid ester show 11 more
- Molecular Framework
- Aromatic heteromonocyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 3A4G3A848U
- CAS number
- 77-15-6
- InChI Key
- WGJHHMKQBWSQIY-UHFFFAOYSA-N
- InChI
- InChI=1S/C16H23NO2/c1-3-19-15(18)16(14-8-5-4-6-9-14)10-7-12-17(2)13-11-16/h4-6,8-9H,3,7,10-13H2,1-2H3
- IUPAC Name
- ethyl 1-methyl-4-phenylazepane-4-carboxylate
- SMILES
- CCOC(=O)C1(CCCN(C)CC1)C1=CC=CC=C1
References
- Synthesis Reference
U.S. Patent 2,666,050.
- General References
- Not Available
- External Links
- KEGG Drug
- D01435
- PubChem Compound
- 6469
- PubChem Substance
- 310264949
- ChemSpider
- 6225
- 24484
- ChEBI
- 135074
- ChEMBL
- CHEMBL170797
- Drugs.com
- Drugs.com Drug Page
- Wikipedia
- Ethoheptazine
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Tablet Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
Property Value Source melting point (°C) 122-124 U.S. Patent 2,666,050. - Predicted Properties
Property Value Source Water Solubility 0.575 mg/mL ALOGPS logP 3.32 ALOGPS logP 2.9 Chemaxon logS -2.7 ALOGPS pKa (Strongest Basic) 8.69 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 29.54 Å2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 77.08 m3·mol-1 Chemaxon Polarizability 29.92 Å3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 162.83455 predictedDeepCCS 1.0 (2019) [M+H]+ 165.19255 predictedDeepCCS 1.0 (2019) [M+Na]+ 171.2857 predictedDeepCCS 1.0 (2019)
Drug created at June 10, 2014 22:04 / Updated at December 02, 2023 07:01